NeuroPace (NPCE) EBITDA Margin (2020 - 2026)
NeuroPace (NPCE) recorded quarterly EBITDA Margin of 25.23% in Q1 2026, down 279.65% quarter-over-quarter from 6.65% in Q4 2025, and down 238.0% on a YoY basis from 18.28% in Q1 2025.
NeuroPace (NPCE) EBITDA Margin (2020 - 2026) Analysis & Trends
NeuroPace's EBITDA Margin history runs 7 years deep, the most recent figure standing at 25.23% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 238.0% year-over-year to 25.23%; the TTM figure through Mar 2026 stood at 16.84% (up 755.0% YoY), while the FY2025 annual figure was 16.34%, up 1078.0% from the prior year.
- EBITDA Margin was 25.23% for Q1 2026 at NeuroPace, down from 6.65% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 6.65% in Q4 2025 to a low of 129.01% in Q2 2022.
- Historically, EBITDA Margin has averaged 50.01% across 5 years, with a median of 39.02% in 2024.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin sank 6158 bps in 2022, then jumped 7375 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 85.39% in 2022, then surged by 60 bps to 34.42% in 2023, then surged by 51 bps to 17.02% in 2024, then surged by 61 bps to 6.65% in 2025, then plunged by 280 bps to 25.23% in 2026.
- The last three EBITDA Margin figures came in at 25.23% (Q1 2026), 6.65% (Q4 2025), and 9.51% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | 21.42% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | 10.04% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 19.94% |
| 10 | NeuroPace | 526.99 Mn | 473.01 Mn | 18.05 Mn | -25.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.23% |
| Dec 31, 2025 | -6.65% |
| Sep 30, 2025 | -9.51% |
| Jun 30, 2025 | -29.01% |
| Mar 31, 2025 | -22.85% |
| Dec 31, 2024 | -17.02% |
| Sep 30, 2024 | -20.15% |
| Jun 30, 2024 | -39.02% |
| Mar 31, 2024 | -49.24% |
| Dec 31, 2023 | -34.42% |
| Sep 30, 2023 | -44.18% |
| Jun 30, 2023 | -55.26% |
| Mar 31, 2023 | -71.69% |
| Dec 31, 2022 | -85.39% |
| Sep 30, 2022 | -104.58% |
| Jun 30, 2022 | -129.01% |
| Mar 31, 2022 | -107.01% |
| Dec 31, 2021 | -100.01% |
| Sep 30, 2021 | -77.97% |
| Jun 30, 2021 | -67.43% |